Perspectum Lands Top Spot in Alantra Pharma Fast 50 Rankings. Read more
Autoimmune Hepatitis (AIH)
Sheila, a retired teacher, was first diagnosed with Autoimmune Hepatitis (AIH) after an episode of jaundice. There’s no cure for AIH but it can be carefully managed via medication. Sheila’s physicians monitored her condition by taking regular blood tests to track the health of her liver. The results of these tests appeared to show that she was responding well to her medication so her doses were lowered.
However, Sheila’s first LiverMultiScan® showed that her inflammation and fibrosis marker, cT1, was still in the range indicating active fibrotic disease. Sheila was scheduled for a routine liver biopsy shortly after, which confirmed the findings of the LiverMultiScan. This led her doctor to increase her medication doses. A second LiverMultiScan taken 6 months later showed a decrease in cT1 which suggested that the inflammation in her liver was getting better.
Sheila commented, "(The report gave) visual clarity that was easy to understand… My consultant tells me he will need to do another liver biopsy in the summer to see how things are. And I am hoping he will look at this (LiverMultiScan report) and not have to do it. Like I say, punching a hole in an already inflamed organ doesn’t seem like a good idea to me."